Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

Company News Summary

Opthea Provides Corporate Presentation

19 Oct 2021  |  09:50:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: Opthea Corporate Presentation - October 2021

Opthea provided corporate presentation. It reported Pivotal Phase 3 trials ongoing, on-track for topline data 2H 2023 and commercial launch 2024. It noted currently available treatment options and those in development focus only on reducing burden of care, OPT-302 is designed to transform patient outcomes by improving vision. FDA granted Fast-Track designation based on superior Phase 2b results.

Please click here for full details

See more ASX300 News Announcements